Blog
Legal resources, updates, and guidance on medication injury claims.
Depo-Provera Users Need to Know: What the FDA's New Label Warning Means for Monitoring and Screening
The FDA's updated Depo-Provera label includes guidance on monitoring and screening. Learn what women who used this contraceptive need to do to protect their health.
Pancreatitis and GLP-1 Drugs: Symptoms, Diagnosis, and Legal Options
Learn how GLP-1 medications like Ozempic increase pancreatitis risk, recognize warning signs, and understand your legal options if you've been harmed.
Depo-Provera Pilot Trial December 2026: What It Means for Your Case
The first Depo-Provera meningioma pilot trial is set for December 2026. Learn what bellwether trials are, what's being argued, potential outcomes, and the impact on settlement.
Depo-Provera and Meningioma: A Timeline of FDA Warnings and Studies
A chronological timeline of the Depo-Provera meningioma link — from early research through the BMJ study, FDA label update, and current litigation milestones.
The Depo-Provera MDL: Case Count, Timeline, and What to Expect
Track the Depo-Provera meningioma MDL: current case count, court proceedings, bellwether selection, Rule 702 hearings, and the December 2026 pilot trial timeline.
Depo-Provera Meningioma Settlements: What Comparable Cases Tell Us
What can comparable pharmaceutical mass tort settlements tell us about potential Depo-Provera meningioma case values? Analysis of factors affecting compensation and timeline expectations.
Depo-Provera vs. Ozempic Lawsuit: Key Differences Explained
Compare the Depo-Provera meningioma lawsuit and the GLP-1/Ozempic lawsuit side by side — drug type, injuries, MDL status, case counts, and settlement timelines.
Can I File a Depo-Provera Lawsuit if I Used It Years Ago?
Wondering if you can still file a Depo-Provera meningioma lawsuit if you used the drug years or decades ago? Learn how the discovery rule and statutes of limitations work.
Which GLP-1 Drugs Are Included in the Ozempic Lawsuit?
Find out which GLP-1 receptor agonist drugs are covered in the Ozempic lawsuit, what injuries qualify, and how the MDL process works for affected patients.
Gastric Emptying Study: Why It Matters for Your Ozempic Claim
Learn what a gastric emptying study (GES) is, how it's performed, and why it's the key diagnostic test for strengthening your Ozempic gastroparesis legal claim.
Mounjaro, Wegovy, Trulicity: GLP-1 Lawsuits Beyond Ozempic
The GLP-1 litigation extends well beyond Ozempic. Learn about lawsuits involving Mounjaro, Wegovy, Trulicity, Saxenda, and Rybelsus — including injury profiles and case counts.
GLP-1 Medications Compared: Ozempic vs. Wegovy vs. Mounjaro vs. Trulicity
A side-by-side comparison of GLP-1 medications involved in the mass tort litigation — Ozempic, Wegovy, Mounjaro, Trulicity, Saxenda, and Rybelsus — including active ingredients, manufacturers, and lawsuit status.
How Mass Tort Lawsuits Work: A Plain-English Guide
A clear, jargon-free guide to mass tort lawsuits: how MDLs differ from class actions, what bellwether trials are, how settlements work, and what clients should expect.
Ozempic and Bowel Obstruction: Symptoms, Risks, and Legal Options
Bowel obstruction is a serious, potentially life-threatening side effect of GLP-1 drugs like Ozempic. Learn about symptoms, emergency risks, and legal claims for affected patients.
Ozempic and Vision Loss (NAION): The Emerging Legal Claims
A Harvard study links GLP-1 drugs like Ozempic to NAION, a serious form of sudden vision loss. Learn about the condition, the research, and your legal options.
Ozempic Gallbladder Disease: Qualifying Injuries in the GLP-1 MDL
Gallstones, cholecystitis, and cholecystectomy after taking Ozempic or other GLP-1 drugs — learn about qualifying gallbladder injuries, FDA warnings, and your legal options.
Already Diagnosed? How to Start Your Mass Tort Claim
A step-by-step guide to filing a mass tort claim after a diagnosis — from gathering documents to filing your case. Covers both Depo-Provera meningioma and GLP-1 drug claims.
What Is a Meningioma? Understanding the Brain Tumor Linked to Depo-Provera
A comprehensive medical explainer on meningioma brain tumors: types, symptoms, diagnosis, treatment options, and the established link to Depo-Provera contraceptive injections.
FDA Warns: Depo-Provera Linked to Meningioma Brain Tumors
In December 2025, the FDA added a warning to Depo-Provera's label linking the contraceptive injection to meningioma brain tumors. Learn what this means for your legal rights.
Do You Qualify for the Depo-Provera Meningioma Lawsuit?
A straightforward guide to determining whether you qualify to file a Depo-Provera meningioma claim. Learn the key eligibility criteria.
Gastroparesis After Ozempic: Symptoms, Diagnosis, and Legal Options
If you developed gastroparesis or other serious stomach problems after taking Ozempic, Wegovy, or Mounjaro, you may have legal options. Here's what you need to know.
Ozempic Lawsuit Update: What You Need to Know in 2026
Over 3,300 cases are now pending in the GLP-1 litigation. Here's where things stand with the Ozempic, Wegovy, and Mounjaro lawsuits as of 2026.